Cheng Y T, Li Y L, Wu J D, Long S B, Tzai T S, Tzeng C C, Lai M D
Department of Biochemistry, College of Medicine, National Cheng Kung University, Tainan, Taiwan, Republic of China.
Mol Carcinog. 1995 Jul;13(3):173-81. doi: 10.1002/mc.2940130307.
To investigate the importance of oncogenes and tumor suppressor genes in bladder carcinogenesis, we determined the status of the expression of the MDM-2 and p53 genes and genetic alterations in the p53 gene in five bladder carcinoma cell lines and one kidney urothelial carcinoma cell line. Overexpression of MDM-2 mRNA was observed in three bladder carcinoma cell lines, J82, SCaBER, and BFTC-905. Amplification of the MDM-2 gene was not detected in any of the six cell lines by southern analysis. The deletion in the p53 gene was observed in J82, and point mutation was detected in J82 and BFTC-909, the kidney urothelial carcinoma cell line. In contrast, no mutations were found in codons 12, 13, and 61 in the Ha-ras and Ki-ras genes in these six cell lines. These results indicate that alterations in the p53-regulated pathway are important in bladder carcinogenesis.
为了研究癌基因和肿瘤抑制基因在膀胱癌发生中的重要性,我们检测了5种膀胱癌细胞系和1种肾尿路上皮癌细胞系中MDM-2和p53基因的表达状态以及p53基因的遗传改变。在3种膀胱癌细胞系J82、SCaBER和BFTC-905中观察到MDM-2 mRNA的过表达。通过Southern分析在这6种细胞系中均未检测到MDM-2基因的扩增。在J82中观察到p53基因的缺失,在J82和肾尿路上皮癌细胞系BFTC-909中检测到点突变。相反,在这6种细胞系的Ha-ras和Ki-ras基因的第12、13和61密码子中未发现突变。这些结果表明p53调节通路的改变在膀胱癌发生中很重要。